Cycurion CEO receives 100,200-share stock award
The July 29, 2026 restricted stock award had a $2.40-per-share issuance price, and the closing market price that day was also $2.40.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Cycurion, Inc. CEO and director Leo Kevin Kelly reported common-stock acquisitions and gift transfers. Award acquisitions included 100,200 shares on July 29, 2026, with a $2.40-per-share issuance price and vesting that day; 36,564 shares on April 26, 2026; 3,527 on May 1, 2026; and 7,102 on December 9, 2025. A footnote linked to those latter three awards states a $23.52-per-share issuance price and July 1, 2026 vesting. Kelly also acquired 157 shares through a special common stock dividend on December 26, 2025, for which he paid no consideration, and reported gift transfers of 8,742 shares on September 28, 2026, and 3,073 on August 19, 2026. Reported share amounts are adjusted for the 1-for-30 reverse split effective October 27, 2025, and the 1-for-8 reverse split effective August 28, 2026. No Rule 10b5-1 plan is reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Common Stock, $0.01 par value per share | 8,742 | $0.00 | $0.00 |
| Gift | Common Stock, $0.01 par value per share F1 | 3,073 | $0.00 | $0.00 |
| Grant/Award | Common Stock, $0.01 par value per share F1, F4 | 100,200 | $0.00 | $0.00 |
| Grant/Award | Common Stock, $0.01 par value per share F1, F2 | 3,527 | $0.00 | $0.00 |
| Grant/Award | Common Stock, $0.01 par value per share F1, F2 | 36,564 | $0.00 | $0.00 |
| Grant/Award | Common Stock, $0.01 par value per share F1, F3 | 157 | $0.00 | $0.00 |
| Grant/Award | Common Stock, $0.01 par value per share F1, F2 | 7,102 | $0.00 | $0.00 |
| holding | Common Stock, $0.01 par value per share F1 | -- | -- | -- |
Footnotes (4)
- F1. Reflects the Reporting Person's beneficial ownership after giving effect to the Company's 1-for-30 reverse stock split, which became effective on October 27, 2025, and the Company's 1-for-8 reverse stock split, which became effective on August 28, 2026. All share amounts reported herein have been adjusted to reflect such reverse stock splits.
- F2. The reported shares were acquired pursuant to a restricted stock award. The issuance price was $23.52 per share. The shares vested on July 1, 2026, at which time the closing market price of the Company's common stock was $4.40 per share.
- F3. Represents shares acquired pursuant to the Company's special common stock dividend and distributed pro rata to stockholders of record. No consideration was paid by the Reporting Person for the acquisition of such shares.
- F4. The reported shares were acquired pursuant to a restricted stock award. The issuance price was $2.40 per share. The shares vested on July 29, 2026, at which time the closing market price of the Company's common stock was $2.40 per share.
Key Figures
Key Terms
restricted stock award financial
special common stock dividend financial
pro rata financial
reverse stock split financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.